Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal abnormalities in two chordomas.

Z Gibas1, M Miettinen, A A Sandberg

  • 1Department of Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.

Cancer Genetics and Cytogenetics
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

Human pathology·1992
Same author

Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

Cancer genetics and cytogenetics·1992
Same author

Application of fluorescence in situ hybridization in hematological disorders.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

Cancer genetics and cytogenetics·1992
Same journal

Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

Cancer genetics and cytogenetics·2010
Same journal

A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

Cancer genetics and cytogenetics·2010
Same journal

A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

Cancer genetics and cytogenetics·2010
Same journal

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

Cancer genetics and cytogenetics·2010
Same journal

Chromosomal imbalances in urinary bladder paraganglioma.

Cancer genetics and cytogenetics·2010
Same journal

A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

Cancer genetics and cytogenetics·2010
See all related articles

Cytogenetic analysis revealed clonal chromosome abnormalities in two sacral chordomas. Consistent involvement of chromosome 21q22 in translocations suggests a specific association with chordoma development.

Area of Science:

  • Oncology
  • Genetics
  • Cytogenetics

Background:

  • Chordomas are rare bone tumors arising from notochordal remnants.
  • Understanding the genetic basis of chordomas is crucial for developing targeted therapies.

Observation:

  • Two sacral chordoma samples underwent detailed cytogenetic analysis.
  • Both tumors exhibited clonal chromosome abnormalities, including numerical and structural aberrations.

Findings:

  • The hypodiploid tumor showed a der(21)t(1;21)(q21;q22) translocation.
  • The near-triploid tumor displayed numerous rearrangements, including a der(21)t(2;21)(q11;q22).
  • Both translocations involved the specific chromosome band 21q22, suggesting a potential role in chordoma pathogenesis.

Related Experiment Videos

Implications:

  • The consistent involvement of 21q22 in chordoma translocations points to a specific chromosomal region associated with this tumor type.
  • Protooncogenes ETS2 and ERG are located at 21q22, warranting further investigation into their role in chordoma.
  • These findings may guide future research into the molecular mechanisms and potential therapeutic targets for chordoma.